EGRX  valuation analysis

Basics
Name: Eagle Pharmaceuticals, Inc
Description: Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Mar 02, 2021
Market cap: $566.28M (1357th)
Sales(TTM): $187.80M (1358th)
Earnings(TTM): $11.99M (1019th)

Value
FFER: 0.51 (why)
Actual price: $43.37
FFEThis is Eagle Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $81.20
Quantile: EGRX is cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Eagle Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Eagle Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Eagle Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Eagle Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry